Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer
Open Access
- 15 April 2024
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 591, 216858
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (19ZR1410600)
This publication has 175 references indexed in Scilit:
- Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancerCancer Communications, 2023
- A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer ImmunotherapyAdvanced Materials, 2022
- Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal CancerJAMA Network Open, 2022
- Use of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerJAMA Oncology, 2021
- Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safetyCancer, 2021
- Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal CancerJAMA Oncology, 2020
- A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancerCancer Medicine, 2019
- Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency StatusJAMA Oncology, 2019
- Role of Local Radiation Therapy in Cancer ImmunotherapyJAMA Oncology, 2015
- Tumor‐induced myeloid‐derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+T‐cell activation eventsEuropean Journal of Immunology, 2013